Guilherme Wesley Peixoto da Fonseca - Search Results

Year	Number of Results
2018	2
2019	4
2020	4
2021	3
2022	4
2023	2
2024	0

1

Current advancements in pharmacotherapy for cancer cachexia.

da Fonseca GWP, Sato R, de Nazaré Nunes Alves MJ, von Haehling S. da Fonseca GWP, et al. Expert Opin Pharmacother. 2023 Apr;24(5):629-639. doi: 10.1080/14656566.2023.2194489. Epub 2023 Mar 30. Expert Opin Pharmacother. 2023. PMID: 36995115 Review.

2

Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?

Sato R, Vatic M, da Fonseca GWP, von Haehling S. Sato R, et al. Among authors: da fonseca gwp. Curr Heart Fail Rep. 2022 Dec;19(6):400-411. doi: 10.1007/s11897-022-00575-w. Epub 2022 Oct 20. Curr Heart Fail Rep. 2022. PMID: 36261756 Free PMC article. Review.

3

Cancer Cachexia and Related Metabolic Dysfunction.

Fonseca GWPD, Farkas J, Dora E, von Haehling S, Lainscak M. Fonseca GWPD, et al. Int J Mol Sci. 2020 Mar 27;21(7):2321. doi: 10.3390/ijms21072321. Int J Mol Sci. 2020. PMID: 32230855 Free PMC article. Review.

4

Birth weight and heart failure: hindsight as an exact science?

Fonseca GWPD, Garfias-Veitl T, von Haehling S. Fonseca GWPD, et al. Eur J Prev Cardiol. 2022 May 6;29(6):968-970. doi: 10.1093/eurjpc/zwac012. Eur J Prev Cardiol. 2022. PMID: 35134156 No abstract available.

5

Sarcopaenia complicating heart failure.

da Fonseca GWP, von Haehling S. da Fonseca GWP, et al. Eur Heart J Suppl. 2019 Dec;21(Suppl L):L20-L23. doi: 10.1093/eurheartj/suz240. Epub 2019 Dec 23. Eur Heart J Suppl. 2019. PMID: 31885508 Free PMC article.

6

The fatter, the better in old age: the current understanding of a difficult relationship.

Fonseca GWPD, von Haehling S. Fonseca GWPD, et al. Curr Opin Clin Nutr Metab Care. 2022 Jan 1;25(1):1-6. doi: 10.1097/MCO.0000000000000802. Curr Opin Clin Nutr Metab Care. 2022. PMID: 34861670 Review.

7

An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.

Fonseca GWPD, von Haehling S. Fonseca GWPD, et al. Expert Opin Pharmacother. 2021 May;22(7):889-895. doi: 10.1080/14656566.2021.1873954. Epub 2021 Jan 25. Expert Opin Pharmacother. 2021. PMID: 33491505 Review.

8

Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials.

Fonseca GWPD, Dworatzek E, Ebner N, Von Haehling S. Fonseca GWPD, et al. Expert Opin Investig Drugs. 2020 Aug;29(8):881-891. doi: 10.1080/13543784.2020.1777275. Epub 2020 Jun 18. Expert Opin Investig Drugs. 2020. PMID: 32476495 Review.

9

Decreased Native T1 Values and Impaired Myocardial Contractility in Anabolic Steroid Users.

de Souza FR, Dos Santos MR, Rochitte CE, Dos Santos RP, Jordão CP, Leite IS, da Fonseca GWP, Fonseca RA, de Oliveira TF, Yonamine M, Pereira RMR, Negrão CE, Alves NNMJ. de Souza FR, et al. Among authors: da fonseca gwp. Int J Sports Med. 2022 Feb;43(2):183-191. doi: 10.1055/a-1518-7953. Epub 2021 Aug 2. Int J Sports Med. 2022. PMID: 34341973

10

A Cell-Based Assessment of the Muscle Anabolic Potential of Blue Whiting (Micromesistius poutassou) Protein Hydrolysates.

Shekoohi N, Amigo-Benavent M, Wesley Peixoto da Fonseca G, Harnedy-Rothwell PA, FitzGerald RJ, Carson BP. Shekoohi N, et al. Among authors: wesley peixoto da fonseca g. Int J Mol Sci. 2023 Jan 19;24(3):2001. doi: 10.3390/ijms24032001. Int J Mol Sci. 2023. PMID: 36768324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year